dr. zakashansky on repeat exposure to parp inhibitors in patients with ovarian cancer
Published 4 years ago • 630 plays • Length 1:09Download video MP4
Download video MP3
Similar videos
-
2:00
dr. zakashansky on the benefit of maintenance olaparib in brca ovarian cancer
-
1:25
dr. zakashansky on solo2 with maintenance olaparib in relapsed brca1/2 ovarian cancer
-
1:22
dr. gunderson on the use of parp inhibitors in all-comers with ovarian cancer
-
58:46
learn all about parp inhibitors with dr jon krell, consultant medical oncologist
-
6:43
sequencing parp inhibitors in advanced ovarian cancer
-
1:47
dr. liu on parp inhibitors in recurrent ovarian cancer
-
0:56
dr. backes on quality of life with parp inhibitors in ovarian cancer
-
2:35
dr. monk on choosing between parp inhibitors in ovarian cancer
-
1:18
dr. backes on treatment selection with parp inhibitors in ovarian cancer
-
6:20
parp inhibitors in recurrent ovarian cancer
-
1:03:39
precision medicine in ovarian cancer with parp inhibitor therapy and companion diagnostics
-
23:15
is it time to change upfront chemotherapy for ovarian cancer?
-
0:58
dr. crafton on the impact of parp inhibitors in recurrent ovarian cancer
-
11:05
parp inhibitors in recurrent ovarian cancer
-
3:06
recurrent ovarian cancer: choosing a parp inhibitor
-
1:05:05
the changing role of parp inhibitors in the treatment of ovarian cancer
-
9:47
can parp inhibitors offer benefit for all patients with platinum-sensitive ovarian cancer?
-
1:15
dr. aghajanian discusses parp inhibitors for the treatment of ovarian cancer
-
1:11
dr. backes discusses parp inhibitor combinations in ovarian cancer